Back to RecallTracker
Health Canada Health products

CellCept (mycophenolate mofetil) and MYFORTIC (mycophenolate sodium) - Serious Risk of Teratogenicity in Mycophenolate-Containing Products

Issued January 18, 2016
Issue
A cumulative review of birth defects has confirmed that mycophenolate is a human teratogen. The evidence showed an increased rate of congenital malformations and spontaneous abortions associated with mycophenolate in comparison with other immunosuppressants.
Hazard description
Product safety